Announcing the Early Success of QHSLab Launch in South Florida
West Palm Beach, FL, Sept. 01, 2020 (GLOBE NEWSWIRE) - Medical Practice Income (MPI), a subsidiary of USA Equities Corp. (OTC Link: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, is proud to announce the early success of the QHSLab launch in South Florida. Since launching the platform on June 30, 2020, 159 medical practices have provided 374 allergy patients with a QHSLab-generated allergen immunotherapy prescription, generating an estimated $664,608 in reimbursement revenue for these physician’s practices.
There are over 450,000 primary care physicians, including licensed nurse practitioners, in the United States. Many are reporting higher rates of fatigue and burnout due to long hours, heavy patient caseloads, and declining practice revenue from a lack of healthcare reimbursements. Primary care physicians are incredibly overwhelmed by the number of patients suffering from allergies, which often signal other health-related and immune compromising concerns. Doctors need smart, digital medicine solutions that save time and money while delivering the right treatment to patients that need it. With the addition of QHSLab, not only will physicians be better equipped to treat patients, but they will also be able to sustain their practices with ongoing revenue through healthcare reimbursements, generating new income per practice per year.
Allergies alone are estimated to affect 1 in every 5 Americans and costs upwards of $18 billion in direct health and medical expenditures annually. It not only impairs quality of life but is responsible for as much as $4 billion annually in lost productivity due to work and school absences. When over-the-counter allergy medication treatment is no longer successful, providers recommend allergen immunotherapy. Allergy specialists usually prepare allergen immunotherapy; however, today, there is a published shortage of board-certified allergy specialists available to treat the number of allergy sufferers.1 A patient must now rely on their primary care provider to effectively manage their allergies. "QHSLab increases the primary care physician's ability to effectively address their patient's chronic conditions while saving them time and potentially expensive visits to a specialist when not necessary," said Troy Grogan, President, and CEO of Medical Practice Income, Inc.
“QHSLab increases the primary care physician’s ability to effectively address their patient’s chronic conditions while saving them time and potentially expensive visits to a specialist when not necessary,”
The Fall of 2020 is soon upon us, but this season will be even more alarming than usual due to the ongoing spread and impact of COVID-19. Fredric Pullen MD, FACS, an Allergy and Ear, Nose & Throat Specialist based in Palm Beach Gardens, FL, shared the following insight regarding QHSLab: "It's so much easier for busy primary care physicians to have a software system that can automatically generate the patient's allergy formulas for their appropriate immunotherapy, based on their allergy test results. It saves time and potential error, which is a definite plus for non-allergy specialist doctors, especially in the age of COVID-19."
For more information about Medical Practice Income, or to become a participating physician, please click here.
Investor & Media Contact:
Olivia Giamanco
Medical Practice Income, Inc.
(929) 374-6503
admin@medicalpracticeincome.com